Telix Pharmaceuticals
TLX.AX
#2620
Rank
NZ$9.17 B
Marketcap
$27.40
Share price
-3.62%
Change (1 day)
161.75%
Change (1 year)

Operating Margin for Telix Pharmaceuticals (TLX.AX)

Operating Margin at the end of 2023: 0.62%

According to Telix Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 0.62%. At the end of 2023 the company had an Operating Margin of 0.62%.

Operating Margin history for Telix Pharmaceuticals from 2018 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20230.62%-100.98%
2022-63.23%-96.15%
2021-1,642.81%60.39%
2020-1,024.25%14.69%
2019-893.03%-88.91%
2018-8,052.54%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.